Study: Real-World Evidence has Limited Use in Managed Care Formulary Decision Making
ISPOR—The Professional Society for Health Economics and Outcomes ResearchValue in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that while payers recognize the value of real-world evidence, the use of such studies to inform pharmacy and therapeutic (P&T) committee decisions is limited.